Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry
From MaRDI portal
Publication:3774792
DOI10.2307/2347264zbMath0635.62106MaRDI QIDQ3774792
No author found.
Publication date: 1986
Published in: Applied Statistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2347264
EM algorithm; Bayes factor; probit model; clinical trials; hierarchical model; pharmacokinetics; prior information; two-stage procedure; cross-over designs; population modelling; historical information; carryover effects; nonlinear random effects models; acute toxicity; bioequivalence assessment; prediction. LD 50 experiments
62P10: Applications of statistics to biology and medical sciences; meta analysis
62F15: Bayesian inference
Related Items
Kullback-leibler information approach to the optimum measurement point for bayesian estimation, A Bayesian Approach for Nonlinear Regression Models with Continuous Errors, A Bayesian Approach to Finite Mixture Models in Bioassay via Data Augmentation and Gibbs Sampling and Its Application to Insecticide Resistance, Uses, Abuses and Misuses of Significance Tests in the Scientific Community: Won't the Bayesian Choice be Unavoidable?, Bayesian index to compare assumed survival functions of two hazards following exponential distributions, Bayesian methods for analysing ringing data, Weak informativity and the information in one prior relative to another, A weakly informative default prior distribution for logistic and other regression models, A Bayesian approach to Weibull survival models -- application to a cancer clinical trial, An approach to evaluating sensitivity in Bayesian regression analyses. (With discussion), Clinician preferences and the estimation of causal treatment differences. (With comments), Hierarchical Bayesian analysis of the carryover effect in two-period crossover designs, On large-sample parametric approaches for interval estimation of the \(ED_{90}\), Goodness of fit for the logistic regression model using relative belief, Approximation of Bayesian predictive \(p\)-values with regression ABC, Incorporating Bayesian ideas into health-care evaluation, Bayesian tests for the balanced two-way analysis of variance model, The Wasserstein impact measure (WIM): a practical tool for quantifying prior impact in Bayesian statistics, Prediction markets, Bayesian priors, and clinical trials, Asymptotic properties of anoya bayes factors, Extended Models for Quantal Response Data, On the multivariate predictive distribution of multi-dimensional effective dose: a Bayesian approach, Critical issues in different inferential paradigms, Estimating treatment effects in clinical crossover trials
